Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2025-04-24 00:00:00 ET · period of report 2025-04-23 · accession 0000950170-25-058137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-24 | 2025-04-23 | KPTI | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $6.17 | -419 | 28.9K | -1% | -$2,585 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-23 | S | D | 419 | $6.17 | 28,853 | D | — | — |